HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuhiko Kizuka Selected Research

alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferase

4/2022Cryostorage of unstable N-acetylglucosaminyltransferase-V by synthetic zwitterions.
1/2022Structure-based design of UDP-GlcNAc analogs as candidate GnT-V inhibitors.
1/2022N-acetylglucosaminyltransferase-V requires a specific noncatalytic luminal domain for its activity toward glycoprotein substrates.
12/2020Recognition of glycan and protein substrates by N-acetylglucosaminyltransferase-V.
1/2018Structure and mechanism of cancer-associated N-acetylglucosaminyltransferase-V.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuhiko Kizuka Research Topics

Disease

18Neoplasms (Cancer)
04/2022 - 01/2015
8Alzheimer Disease (Alzheimer's Disease)
08/2021 - 02/2015
4Emphysema
11/2018 - 04/2014
4Chronic Obstructive Pulmonary Disease (COPD)
11/2018 - 09/2015
3Neoplasm Metastasis (Metastasis)
01/2021 - 01/2015
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 01/2016
2Melanoma (Melanoma, Malignant)
01/2019 - 01/2019
2Inflammation (Inflammations)
12/2017 - 01/2017
2Demyelinating Diseases (Demyelinating Disease)
01/2017 - 06/2013
1Autoimmune Diseases (Autoimmune Disease)
01/2022
1Prion Diseases (Transmissible Spongiform Encephalopathies)
01/2022
1Pathologic Processes
01/2021
1Thrombosis (Thrombus)
01/2021
1Experimental Melanoma
01/2019
1Pneumonia (Pneumonitis)
11/2018
1Hepatocellular Carcinoma (Hepatoma)
12/2017
1Pulmonary Emphysema
11/2017
1Obesity
10/2017
1Nervous System Diseases (Neurological Disorders)
11/2016
1Parkinson Disease (Parkinson's Disease)
04/2016
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
04/2016
1Oligodendroglioma
10/2014
1Disease Progression
04/2014

Drug/Important Bio-Agent (IBA)

20Polysaccharides (Glycans)IBA
01/2022 - 06/2013
11EnzymesIBA
04/2022 - 01/2015
9Proteins (Proteins, Gene)FDA Link
04/2022 - 02/2015
7FucoseIBA
12/2017 - 04/2014
5alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA
04/2022 - 01/2018
5Pharmaceutical PreparationsIBA
01/2022 - 02/2015
5SugarsIBA
01/2021 - 01/2015
4GlycosyltransferasesIBA
01/2021 - 04/2014
3NucleotidesIBA
01/2021 - 01/2015
3Amyloid (Amyloid Fibrils)IBA
01/2016 - 02/2015
2Biological ProductsIBA
01/2021 - 01/2015
2Glycoproteins (Glycoprotein)IBA
01/2021 - 09/2015
2FucosyltransferasesIBA
01/2021 - 11/2017
2DisaccharidesIBA
11/2018 - 01/2017
2Keratan SulfateIBA
11/2018 - 01/2017
2CuprizoneIBA
01/2017 - 06/2013
2SmokeIBA
01/2017 - 09/2015
2Biomarkers (Surrogate Marker)IBA
04/2016 - 09/2015
2Peptide Hydrolases (Proteases)FDA Link
01/2016 - 02/2015
2LectinsIBA
09/2015 - 01/2015
1Biocompatible Materials (Biomaterials)IBA
04/2022
1AcetylgalactosamineIBA
01/2022
1UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferaseIBA
01/2022
1PrionsIBA
01/2022
1TransferasesIBA
01/2021
1GlycolipidsIBA
01/2021
1Glycoside Hydrolases (Endoglycosidases)IBA
01/2021
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2021
1Proteoglycans (Proteoglycan)IBA
01/2021
1N-AcetylglucosaminyltransferasesIBA
01/2021
1AcetylglucosamineIBA
12/2020
1dolichyl-diphosphooligosaccharide - protein glycotransferase (oligosaccharyltransferase)IBA
12/2019
1Sucrose (Saccharose)IBA
01/2019
1AsparagineIBA
01/2019
1Detergents (Detergent)IBA
01/2019
1C-Type Lectins (C-Type Lectin)IBA
11/2018
1GlycosaminoglycansIBA
11/2018
1IntegrinsIBA
01/2018
1Angiogenesis InhibitorsIBA
01/2018
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2018
1Cell Surface ReceptorsIBA
01/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018
1Guanosine Diphosphate Fucose (GDP Fucose)IBA
12/2017
1Toll-Like Receptor 4IBA
11/2017
1Mannose (D-Mannose)IBA
01/2017
1Pancreatic Elastase (Elastase)IBA
01/2017
1CytokinesIBA
01/2017
1AntibodiesIBA
01/2017
1Matrix Metalloproteinases (MMPs)IBA
01/2017
1Peroxidase (Myeloperoxidase)IBA
01/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2016
1Reactive Nitrogen SpeciesIBA
04/2016
1GlycoconjugatesIBA
01/2016
1AntioxidantsIBA
01/2016
1Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
09/2015
1Peptides (Polypeptides)IBA
02/2015
1alpha-1,3-mannosylglycoprotein beta-1,4-N-acetylglucosaminyltransferaseIBA
01/2015
1Tumor Biomarkers (Tumor Markers)IBA
01/2015
1LuciferasesIBA
10/2014
1Transcription Factors (Transcription Factor)IBA
10/2014

Therapy/Procedure

2Therapeutics
04/2016 - 01/2015